Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Biotech Finland Oy
OY
Active
Y-tunnus 2774269-6
As. 2, 24280
Salo
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2016 · 9 years old
1 employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Biotech Finland Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
0M
2026
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
0M
0%
2026
Income statement
EUR thousands
Item
2022
2023
2024
2025
2026
Revenue
153
0
162
167
202
Staff expenses
−63
−0
−68
−69
−67
EBITDA
17
0
37
5
63
Depreciation & amort.
—
−0
−5
−4
−3
EBIT
17
0
33
1
61
Net financials
9
0
1
4
1
Profit before tax
26
0
33
1
66
Tax
5
−0
7
0
13
Net profit
20
0
27
1
53
Balance sheet
EUR thousands
Item
2022
2023
2024
2025
2026
Total assets
75
88
113
106
152
Equity
64
72
93
87
133
Long-term debt
—
0
0
0
0
Short-term debt
11
15
19
20
19
Total debt
11
15
19
20
19
Financial ratios
5-year trend
EBITDA margin
31.4%
This company
15.8%
Market median
+99% vs market
2022
2026
Equity ratio
87.7%
This company
38.2%
Market median
+130% vs market
2022
2026
Return on equity
40.2%
This company
18.4%
Market median
+118% vs market
2022
2026
Net profit margin
26.5%
This company
8.1%
Market median
+227% vs market
2022
2026
Asset turnover
1.33×
This company
1.12×
Market median
+19% vs market
2022
2026
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
2022
2026
Annual reports & filings
Annual report 2026
Filed via PRH / YTJ · Period 2025-02-01 – 2026-01-31
View
PDF
Annual report 2025
Filed via PRH / YTJ · Period 2024-02-01 – 2025-01-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-02-01 – 2024-01-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-02-01 – 2023-01-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-02-01 – 2022-01-31
View
PDF
More on Biotech Finland Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
